State of the art radiation therapy for lung cancer 2012: A glimpse of the future

Clinical Lung Cancer

Volumn 14, Issue 2, 2013, Pages 89-95

  De Ruysscher, Dirk ^a   Belderbos, José ^b   Reymen, Bart ^a   Van Elmpt, Wouter ^a   Van Baardwijk, Angela ^a   Wanders, Rinus ^a   Hoebers, Frank ^a   Vooijs, Marc ^a   Öllers, Michel ^a   Lambin, Philippe ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

Author keywords

Decision support; Individualized; Non small cell lung cancer; Radiation therapy; Small cell lung cancer; Tumor heterogeneity

Indexed keywords

CANCER PATIENT; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CHEMORADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; ELECTRONIC PORTAL IMAGING DEVICE; HUMAN; HYPERFRACTIONATION; INTENSITY MODULATED RADIATION THERAPY; LUNG CANCER; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; MEDICAL DECISION MAKING; MEDICAL DEVICE; PATIENT SELECTION; POSITRON EMISSION TOMOGRAPHY; RADIATION DOSE; RADIATION DOSE FRACTIONATION; REVIEW; SKULL IRRADIATION; STEREOTACTIC BODY RADIATION THERAPY;

CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SMALL CELL; CHEMORADIOTHERAPY; CRANIAL IRRADIATION; DOSE FRACTIONATION; HUMANS; LUNG NEOPLASMS; RADIOSURGERY; RADIOTHERAPY, IMAGE-GUIDED; RADIOTHERAPY, INTENSITY-MODULATED;

EID: 84875259950     PISSN: 15257304     EISSN: 19380690     Source Type: Journal    
DOI: 10.1016/j.cllc.2012.06.006     Document Type: Review

References (66)

1. Simard EP, Ward EM, Siegel R, et al. Cancers with increasing incidence trends in the United States: 1999 through 2008. CA Cancer J Clin, Published online January 4, 2012; doi: 10.3322/caac.20141.
2. P. Rubin, R. Brasacchio, A. Katz Solitary metastases: illusion versus reality Semin Radiat Oncol 16 2006 120 130
3. R. Timmerman, R. Paulus, J. Galvin Stereotactic body radiation therapy for inoperable early stage lung cancer JAMA 303 2010 1070 1076
4. E.M. Bongers, C.J. Haasbeek, F.J. Lagerwaard Incidence and risk factors for chest wall toxicity after risk-adapted stereotactic radiotherapy for early-stage lung cancer J Thorac Oncol 6 2011 2052 2057
5. M. Guckenberger, L.L. Kestin, A.J. Hope Is there a lower limit of pretreatment pulmonary function for safe and effective stereotactic body radiotherapy for early-stage non-small cell lung cancer? J Thorac Oncol 7 2012 542 551
6. D. Palma, O. Visser, F.J. Lagerwaard Impact of introducing stereotactic lung radiotherapy for elderly patients with stage I non-small-cell lung cancer: a population-based time-trend analysis J Clin Oncol 28 2010 5153 5159
7. D.J. Hoopes, M. Tann, J.W. Fletcher FDG-PET and stereotactic body radiotherapy (SBRT) for stage I non-small-cell lung cancer Lung Cancer 56 2007 229 234
8. M. Dahele, D. Palma, F. Lagerwaard Radiological changes after stereotactic radiotherapy for stage I lung cancer J Thorac Oncol 6 2011 1221 1228
9. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials Non-small Cell Lung Cancer Collaborative Group BMJ 311 1995 899 909
10. A. Aupérin, C. Le Péchoux, E. Rolland Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer J Clin Oncol 28 2010 2181 2190
11. K.S. Albain, R.S. Swann, V.W. Rusch Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial Lancet 374 2009 379 386
12. J.P. van Meerbeeck, G.W. Kramer, P.E. Van Schil Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small-cell lung cancer J Natl Cancer Inst 99 2007 442 450
13. J. Vansteenkiste, D. Betticher, W. Eberhardt Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small cell lung cancer J Thorac Oncol 2 2007 684 685
14. K.S. Albain, V.W. Rusch, J.J. Crowley Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer: mature results of southwest Oncology Group phase II study 8805 J Clin Oncol 13 1995 1880 1892
15. C. Pöttgen, W. Eberhardt, S. Bildat Induction chemotherapy followed by concurrent chemotherapy and definitive high-dose radiotherapy for patients with locally advanced non-small-cell lung cancer (stages IIIa/IIIb): a pilot phase I/II trial Ann Oncol 13 2002 403 411
16. N. Lorent, P. De Leyn, Y. Lievens Long-term survival of surgically staged IIIA-N2 non-small-cell lung cancer treated with surgical combined modality approach: analysis of a 7-year prospective experience Ann Oncol 15 2004 1645 1653
17. D.C. Betticher, S.F. Hsu Schmitz, M. Tötsch Prognostic factors affecting long-term outcomes in patients with resected stage IIIA pN2 non-small-cell lung cancer: 5-year follow-up of a phase II study Br J Cancer 94 2006 1099 1106
18. P. Garrido, J.L. González-Larriba, A. Insa Long-term survival associated with complete resection after induction chemotherapy in stage IIIA (N2) and IIIB (T4N0-1) non small-cell lung cancer patients: the Spanish Lung Cancer Group trial 9901 J Clin Oncol 25 2007 4736 4742
19. M. Machtay, C. Hsu, R. Komaki Effect of overall treatment time on outcomes after concurrent chemoradiation for locally advanced non-small-cell lung carcinoma: analysis of the radiation therapy Oncology Group (RTOG) experience Int J Radiat Oncol Biol Phys 63 2005 667 671
20. M. Machtay, K. Bae, B. Movsas Higher biologically effective dose of radiotherapy is associated with improved outcomes for locally advanced non-small cell lung carcinoma treated with chemoradiation: an analysis of the radiation therapy Oncology Group Int J Radiat Oncol Biol Phys 82 2012 425 434
21. D. De Ruysscher, A. Botterweck, M. Dirx Eligibility for concurrent chemotherapy and radiotherapy of locally advanced lung cancer patients: a prospective, population-based study Ann Oncol 20 2009 98 102
22. D. De Ruysscher, V. Khoo, S.M. Bentzen Biological basis of fractionation and timing of radiotherapy H.I. Pass, D.P. Carbone, D.H. Johnson, Lung Cancer: Principles and Practice 4th ed. 2009 Lippincott Williams & Wilkins Philadelphia 569 588
23. M. Saunders, S. Dische, A. Barrett Continuous, hyperfractionated, accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: mature data from the randomised multicentre trial CHART Steering Committee Radiother Oncol 52 1999 137 148
24. C.P. Belani, W. Wang, D.H. Johnson Phase III study of the Eastern Cooperative Oncology Group (ECOG 2597): induction chemotherapy followed by either standard thoracic radiotherapy or hyperfractionated accelerated radiotherapy for patients with unresectable stage IIIA and B non-small-cell lung cancer J Clin Oncol 23 2005 3760 3767
25. P. Jenkins, S. Anderson, S. Wronski A phase II trial of induction chemotherapy followed by continuous hyperfractionated accelerated radiotherapy in locally advanced non-small-cell lung cancer Radiother Oncol 93 2009 396 401
26. M. Baumann, T. Herrmann, R. Koch Final results of the randomized phase III CHARTWEL-trial (ARO 97-1) comparing hyperfractionated-accelerated versus conventionally fractionated radiotherapy in non-small cell lung cancer (NSCLC) Radiother Oncol 100 2011 76 85
27. M. Stuschke, C. Pottgen Altered fractionation schemes in radiotherapy Front Radiat Ther Oncol 42 2010 150 156
28. A. van Baardwijk, G. Bosmans, S.M. Bentzen Radiation dose prescription for non-small-cell lung cancer according to normal tissue dose constraints: an in silico clinical trial Int J Radiat Oncol Biol Phys 71 2008 1103 1110
29. A. van Baardwijk, S. Wanders, L. Boersma Mature results of an individualized radiation dose prescription study based on normal tissue constraints in stages I to III non-small-cell lung cancer J Clin Oncol 28 2010 1380 1386
30. van Baardwijk A, Wanders R, Reymen B, et al. First results of a phase II trial investigating individualized dose-escalation based on normal tissue constraints in Concurrent chemo-radiation for locally advanced non-small cell lung cancer. Eur J Cancer, Published online May 17, 2012 [Epub ahead of print].
31. F.M. Kong, X. Ao, L. Wang The use of blood biomarkers to predict radiation lung toxicity: a potential strategy to individualize thoracic radiation therapy Cancer Contr 15 2008 140 150
32. D. De Ruysscher, A. Houben, H.J. Aerts Increased (18)F-deoxyglucose uptake in the lung during the first weeks of radiotherapy is correlated with subsequent Radiation-induced lung toxicity (RILT): a prospective pilot study Radiother Oncol 91 2009 415 420
33. C. Dehing-Oberije, H. Aerts, S. Yu Development and validation of a prognostic model using blood biomarker information for prediction of survival of non-small-cell lung cancer patients treated with combined chemotherapy and radiation or radiotherapy alone (NCT00181519, NCT00573040, and NCT00572325) Int J Radiat Oncol Biol Phys 81 2011 360 368
34. C. Dehing-Oberije, D. De Ruysscher, S. Petit Development, external validation and clinical usefulness of a practical prediction model for radiation-induced dysphagia in lung cancer patients Radiother Oncol 97 2010 455 461
35. U. Nestle, S. Kremp, A.L. Grosu Practical integration of [18F]-FDG-PET and PET-CT in the planning of radiotherapy for non-small cell lung cancer (NSCLC): the technical basis, ICRU-target volumes, problems, perspectives Radiother Oncol 81 2006 209 225
36. A. van der Wel, S. Nijsten, M. Hochstenbag Increased therapeutic ratio by 18FDG-PET CT planning in patients with clinical CT stage N2-N3M0 non-small-cell lung cancer: a modeling study Int J Radiat Oncol Biol Phys 61 2005 649 655
37. D. De Ruysscher, S. Wanders, E. van Haren Selective mediastinal node irradiation based on FDG-PET scan data in patients with non-small-cell lung cancer: a prospective clinical study Int J Radiat Oncol Biol Phys 62 2005 988 994
38. J.S. Belderbos, W.D. Heemsbergen, K. De Jaeger Final results of a phase I/II dose escalation trial in non-small-cell lung cancer using three-dimensional conformal radiotherapy Int J Radiat Oncol Biol Phys 66 2006 126 134
39. R.J. Steenbakkers, J.C. Duppen, I. Fitton Observer variation in target volume delineation of lung cancer related to radiation oncologist-computer interaction: a 'Big Brother' evaluation Radiother Oncol 77 2005 182 190
40. C.B. Caldwell, K. Mah, Y.C. Ung Observer variation in contouring gross tumor volume in patients with poorly defined non-small-cell lung tumors on CT: the impact of 18FDG-hybrid PET fusion Int J Radiat Oncol Biol Phys 51 2001 923 931
41. M. Werner-Wasik, A.D. Nelson, W. Choi What is the best way to contour lung tumors on PET scans? Multiobserver validation of a gradient-based method using a NSCLC digital PET phantom Int J Radiat Oncol Biol Phys 82 2012 1164 1171
42. A. van Baardwijk, G. Bosmans, L. Boersma PET-CT-based auto-contouring in non-small-cell lung cancer correlates with pathology and reduces interobserver variability in the delineation of the primary tumor and involved nodal volumes Int J Radiat Oncol Biol Phys 68 2007 771 778
43. H.J. Aerts, G. Bosmans, A.A. van Baardwijk Stability of 18F-deoxyglucose uptake locations within tumor during radiotherapy for NSCLC: a prospective study Int J Radiat Oncol Biol Phys 71 2008 1402 1407
44. H.J. Aerts, A.A. van Baardwijk, S.F. Petit Identification of residual metabolic-active areas within individual NSCLC tumours using a pre-radiotherapy (18)fluorodeoxyglucose-PET-CT scan Radiother Oncol 91 2009 386 392
45. Y. Cui, J.G. Dy, G.C. Sharp Robust fluoroscopic respiratory gating for lung cancer radiotherapy without implanted fiducial markers Phys Med Biol 52 2007 741 755
46. P.J. Keall, A.D. Todor, S.S. Vedam On the use of EPID-based implanted marker tracking for 4D radiotherapy Med Phys 31 2004 3492 3499
47. G.S. Mageras, E. Yorke Deep inspiration breath hold and respiratory gating strategies for reducing organ motion in radiation treatment Semin Radiat Oncol 14 2004 65 75
48. P.J. Keall, S. Joshi, S.S. Vedam Four-dimensional radiotherapy planning for DMLC-based respiratory motion tracking Med Phys 32 2005 942 951
49. J.W. Wolthaus, C. Schneider, J.J. Sonke Mid-ventilation CT scan construction from four-dimensional respiration-correlated CT scans for radiotherapy planning of lung cancer patients Int J Radiat Oncol Biol Phys 65 2006 1560 1571
50. I.S. Grills, D. Yan, A.A. Martinez Potential for reduced toxicity and dose escalation in the treatment of inoperable non-small-cell lung cancer: a comparison of intensity-modulated radiation therapy (IMRT), 3D conformal radiation, and elective nodal irradiation Int J Radiat Oncol Biol Phys 57 2003 875 890
51. M. Schwarz, M. Alber, J.V. Lebesque Dose heterogeneity in the target volume and intensity-modulated radiotherapy to escalate the dose in the treatment of non-small-cell lung cancer Int J Radiat Oncol Biol Phys 62 2005 561 570
52. R.I. Berbeco, F. Hacker, D. Ionascu Clinical feasibility of using an EPID in CINE mode for image-guided verification of stereotactic body radiotherapy Int J Radiat Oncol Biol Phys 69 2007 258 266
53. J.J. Sonke, L. Zijp, P. Remeijer Respiratory correlated cone beam CT Med Phys 32 2005 1176 1186
54. B. Cho, Y. Suh, S. Dieterich A monoscopic method for real-time tumour tracking using combined occasional x-ray imaging and continuous respiratory monitoring Phys Med Biol 53 2008 2837 2855
55. T.G. Purdie, J.P. Bissonnette, K. Franks Cone-beam computed tomography for on-line image guidance of lung stereotactic radiotherapy: localization, verification, and intrafraction tumor position Int J Radiat Oncol Biol Phys 68 2007 243 252
56. J.J. Sonke, J. Lebesque, M. van Herk Variability of four-dimensional computed tomography patient models Int J Radiat Oncol Biol Phys 70 2008 590 598
57. E. Schaake, J. Belderbos, S. Rit Detailed analysis of tumor regression during radical radiotherapy in lung cancer patients J Thorac Oncol S6 2011 S430 S431
58. D.B. Fried, D.E. Morris, C. Poole Systematic review evaluating the timing of thoracic radiation therapy in combined modality therapy for limited-stage small-cell lung cancer J Clin Oncol 22 2004 4837 4845
59. M. Pijls-Johannesma, D. De Ruysscher, J. Vansteenkiste Timing of chest radiotherapy in patients with limited stage small cell lung cancer: a systematic review and meta-analysis of randomised controlled trials Cancer Treat Rev 33 2007 461 473
60. A.T. Turrisi 3rd, K. Kim, R. Blum Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide N Engl J Med 340 1999 265 371
61. D. De Ruysscher, M. Pijls-Johannesma, S.M. Bentzen Time between the first day of chemotherapy and the last day of chest radiation is the most important predictor of survival in limited-disease small-cell lung cancer J Clin Oncol 24 2006 1057 1063
62. D. De Ruysscher, R.H. Bremer, F. Koppe Omission of elective node irradiation on basis of CT-scans in patients with limited disease small cell lung cancer: a phase II trial Radiother Oncol 80 2006 307 312
63. J. van Loon, D. De Ruysscher, R. Wanders Selective nodal irradiation on basis of (18)FDG-PET scans in limited-disease small-cell lung cancer: a prospective study Int J Radiat Oncol Biol Phys 77 2010 329 336
64. S.M. Shirvani, R. Komaki, J.V. Heymach Positron emission tomography/computed tomography-guided intensity-modulated radiotherapy for limited-stage small-cell lung cancer Int J Radiat Oncol Biol Phys 82 2012 e91 e97
65. B. Slotman, C. Faivre-Finn, G. Kramer Prophylactic cranial irradiation in extensive small-cell lung cancer N Engl J Med 357 2007 664 672
66. D. De Ruysscher, M. Mark Lodge, B. Jones Charged particles in radiotherapy: a 5-year update of a systematic review Radiother Oncol 103 2012 5 7